Cure My Disease

Don't miss your cure!

 Log in / Sign up

Antioxidant pill may shield skin from city smog

NCT ID NCT07793123

Symptom relief Sponsor: Robertet SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

Researchers are testing whether a daily oral antioxidant supplement can improve skin radiance in healthy women aged 35 to 65 who live in urban areas and are exposed to air pollution. The trial gives participants either the supplement or a placebo for 90 days, then measures skin radiance, tone, pigmentation, and other skin health markers. The goal is to see if the supplement can counteract some of the skin dullness linked to city living.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an oral antioxidant dietary supplement
What this could lead to
If it works, this could point toward a simple daily supplement that helps protect skin from the visible effects of urban air pollution.
What could go wrong
This is a small, early-stage trial with 60 participants, so results may not apply to everyone. The supplement may not improve skin radiance, and any benefits could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy female aged 35 to 65 years * Fitzpatrick skin phototype II to IV * All skin types * Dull and uneven skin tone * Living in an urban environment and exposed to air pollution * Able to comply with study procedures * Written informed consent provided Exclusion Criteria: * Pregnant or breastfeeding * Current use of dietary supplements or vitamin supplements * Specific dietary restrictions * Unstable medication affecting water retention * Active medical disease * Facial dermatological disorder * Participation in another clinical trial * Vulnerable populations according to French regulations

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy women are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy women

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gredeco

    Paris, 75 013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.